Outcomes in resected ampullary cancer: Difficult decision-making in an uncommon heterogeneous malignancy.
暂无分享,去创建一个
[1] B. Sheppard,et al. Oncologic outcomes in resected ampullary cancer: Relevance of histologic subtype and adjuvant chemotherapy. , 2021, American journal of surgery.
[2] R. Salem,et al. Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma. , 2019, JAMA surgery.
[3] M. Choti,et al. Association of Adjuvant Therapy with Improved Survival in Ampullary Cancer: A National Cohort Study , 2018, Journal of Gastrointestinal Surgery.
[4] B. Teh,et al. Defining the Molecular Alterations of Ampullary Carcinoma. , 2016, Cancer cell.
[5] J. Vauthey,et al. Return to intended oncologic treatment (RIOT): A novel metric for evaluating the quality of oncosurgical therapy for malignancy , 2014, Journal of surgical oncology.
[6] C. Ko,et al. Survival After Resection of Ampullary Carcinoma: A National Population-Based Study , 2008, Annals of Surgical Oncology.